Seth Berkley, the outgoing CEO of Gavi, the Vaccine Alliance said so much energy went into calling for patent waivers for COVID-19 vaccines instead of getting companies to be transparent on where doses were going.
“You know, it was a challenge. Because here we were in the middle of this emergency, and there was a whole community that said, this is what we have to do, and focused on it and pushed on it, and it was irrelevant,” Berkley said at an event on Tuesday hosted by the Center for Global Development.
Berkley has on several occasions mentioned that a waiver would have made no difference in getting the vaccines to low- and middle-income countries, saying it’s all about “know-how.”
Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).
About the author
Jenny Lei Ravelo@JennyLeiRavelo
Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.
